Published on:

News Roundup

  • Santarus files for approval to FDA for anti-swelling drug Rhucin
  • Prescription Drug Coverage Is an Important Part of Your Health Care: Medicare Part D Needs to be Considered
  • Bone-Damage Concerns Lead to Halt of Pain-Drug Tests -Bloomberg
  • FDA Needs Four More Weeks to Review MannKind’s Diabetes Drug Afrezza
Posted in:
Published on:
Updated:

Comments are closed.